Telehealth company Cerebral to pay nearly $3.7M over prescribing practices
Regulators allege the online mental health company attempted to increase prescriptions of drugs like Adderall to boost revenue.
Regulators allege the online mental health company attempted to increase prescriptions of drugs like Adderall to boost revenue.
Still, gross spending on the drugs increased by more than 500% from 2019 to 2023, according to the health policy research firm.
Dramatic growth in an opaque Medicaid funding mechanism is exacerbating concerns about the program’s fiscal integrity — while spurring financial gains for the hospital industry.
Government officials and security leaders are hoping the nation’s need for cyber resilience will transcend partisan politics regardless of the election results.
The deal includes more than 70 urgent care and physical therapy clinics, which Novant said would complement its portfolio in South Carolina.
Last week, the 5th Circuit Court of Appeals sided with the federal government’s original interpretation of the No Surprises Act in determining how a key metric in billing disputes is calculated.
Physicians will see their Medicare reimbursement fall 2.9% next year if Congress doesn’t stop the cuts. Meanwhile, reimbursement for hospital outpatient departments is rising 2.9%.
Tarver is taking over as director of the Center for Devices and Radiological Health as the regulator grapples with questions around artificial intelligence in medical devices and racial bias in pulse oximeters.
The payer joins several other insurers suing federal regulators over the 2025 quality ratings, which Elevance argues will cost it at least $375 million in bonus payments and rebates.
There’s no doubt that AI and GenAI can speed up healthcare innovation. But before organizations can jump into the future, it’s crucial to understand the benefits – and the risks – of advanced technology.